 Shares of ReShape Lifesciences to commence trading on The Nasdaq Capital Market on June 16, 2021 under ticker symbol RSLS Combination creates opportunity for ReShape to expand portfolio of FDA approved weight loss solutions and reimbursed virtual care services SAN CLEMENTE, CA ACCESSWIRE June 16, 2021 ReShape Lifesciences Inc. NASDAQ:RSLS, a global weight-loss solutions leader, today announced the completion of the previously announced merger with Obalon Therapeutics. In connection with the mergers closing, Obalon changed its name to ReShape Lifesciences Inc. and the combined companys common stock will begin trading under the ticker symbol RSLS on The Nasdaq Capital Market beginning on June 16, 2021. 